Immune-related adverse events as a predictor marker of response to programmed cell death 1/programmed death-ligand 1 axis inhibitors in patients with non-small cell lung cancer

Mapping Intimacies ◽

10.1183/13993003.congress-2021.pa2305 ◽

2021 ◽

Author(s):

Andriani Charpidou ◽

Vasilios Patriarcheas ◽

Ioannis Vathiotis ◽

Eleni Kokotou ◽

Nikos Syrigos ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Programmed Cell Death 1

Download Full-text

Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.06.06 ◽

2019 ◽

Vol 8 (S4) ◽

pp. S364-S368 ◽

Author(s):

Maria Jove ◽

Noelia Vilariño ◽

Ernest Nadal

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Programmed Cell Death 1

Download Full-text

Blood-borne cytokines for predicting clinical benefits and immune-related adverse events in advanced non-small cell lung cancer treated with anti- programmed cell death 1 inhibitors

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.007 ◽

2021 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Koichi Sato ◽

Shunsuke Teraoka ◽

Nahomi Tokudome ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Cell Death 1 ◽

Clinical Benefits

Download Full-text

Abstract 1323: Both programmed cell death protein 1 and programmed death-ligand 1 molecules can be expressed on the cell surface of small-cell lung cancer

10.1158/1538-7445.am2015-1323 ◽

2015 ◽

Author(s):

Hiromichi Yamane ◽

Hideko Isozaki ◽

Nobuaki Ochi ◽

Kenichiro Kudo ◽

Yoshihiro Honda ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Cell Surface ◽

Small Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Cell Death Protein

Download Full-text

Association of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort

Annals of Oncology ◽

10.1093/annonc/mdx390.002 ◽

2017 ◽

Vol 28 ◽

pp. v573-v574

Author(s):

K.M. Kerr ◽

E. Thunnissen ◽

U. Dafni ◽

A. Soltermann ◽

S. Finn ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Molecular Alterations ◽

Programmed Cell Death 1 ◽

Download Full-text

Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer

Oncology Reports ◽

10.3892/or.2017.5894 ◽

2017 ◽

Vol 38 (4) ◽

pp. 2277-2284 ◽

Author(s):

Soichiro Funaki ◽

Yasushi Shintani ◽

Tomohiro Kawamura ◽

Ryu Kanzaki ◽

Masato Minami ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Epithelial Mesenchymal Transition ◽

Small Cell Lung ◽

Mesenchymal Transition ◽

Programmed Cell Death 1

Download Full-text

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer

Frontiers in Immunology ◽

10.3389/fimmu.2018.01513 ◽

2018 ◽

Vol 9 ◽

Author(s):

Zibing Wang ◽

Xiaoli Liu ◽

Brian Till ◽

Miaomiao Sun ◽

Xiang Li ◽

...

Keyword(s):

Lung Cancer ◽

Renal Cell Carcinoma ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Therapeutic Efficacy ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

Annals of Oncology ◽

10.1016/j.annonc.2019.11.015 ◽

2020 ◽

Vol 31 (3) ◽

pp. 404-411 ◽

Author(s):

J.F. Gainor ◽

H. Rizvi ◽

E. Jimenez Aguilar ◽

F. Skoulidis ◽

B.Y. Yeap ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Activity ◽

Small Cell Lung ◽

Programmed Cell Death 1 ◽

Download Full-text

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung Cancer (NSCLC)

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2017.05.002 ◽

2017 ◽

Vol 12 ◽

pp. 6-13 ◽

Author(s):

Foluso Ogunleye ◽

LeAnn Blankenship ◽

Vanessa Millisor ◽

Joseph Anderson ◽

Ishmael Jaiyesimi

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

New Era ◽

Programmed Cell Death 1

Download Full-text

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

JMA Journal ◽

10.31662/jmaj.2019-0005 ◽

2019 ◽

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cell Death Protein

Download Full-text

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis

Internal Medicine ◽

10.2169/internalmedicine.3018-19 ◽

2019 ◽

Vol 58 (21) ◽

pp. 3129-3132 ◽

Author(s):

Takahiro Yamada ◽

Takeshi Masuda ◽

Kakuhiro Yamaguchi ◽

Shinjiro Sakamoto ◽

Yasushi Horimasu ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Granulomatosis With Polyangiitis ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text